News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Fresh tissue- Various Cancer Types

Study Status:

Open for enrollment

Contact Information:

(956) 362-2384

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This study is designed to evaluate biomarkers in samples of patients with cancer. In many cases, the investigation is to identify novel markers to create new anti-cancer therapies and companion diagnostics. The biomarkers could be present in plasma, serum, or the tumor tissue itself. In addition, some tumors will be used in a culture environment to determine the efficacy of novel anti-cancer drugs. In addition, some tissues will be mined to isolate, purify, and culture tumor infiltrating lymphocytes, to evaluate immune reactivity in patients.

Information: 

Principal Investigator
Dr. Sohail Rao
Co-PI
Odalys Salinas
Sponsor
MT Group
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram